ADUS vs CHE
ADUS: A leading provider of home-based personal care, hospice, and home health services designed to lower healthcare costs by keeping aging populations independent in their own homes. CHE: Chemed Corporation is a diversified provider of hospice and palliative care services via VITAS Healthcare and professional plumbing and drain cleaning services through Roto-Rooter.
Side-by-side fundamentals
| Metric | ADUS | CHE | Edge |
|---|---|---|---|
| Price as of 2026-10-09 close | $114.33 | $499.82 | |
| Market cap | $2.1B | $6.5B | |
| P/E as of 2026-10-09 | 20.04 | 25.09 | ADUS lower |
| PEG as of 2026-10-09, 3-year EPS CAGR to FY2025 | 0.89 | 7.12 | ADUS lower |
| Net margin FY2025, SEC XBRL | +6.7% | +10.5% | CHE higher |
| Gross margin FY2025, SEC XBRL | +32.5% | n/a | |
| Operating margin FY2025, SEC XBRL | +9.7% | +13.4% | CHE higher |
| ROE FY2025, SEC XBRL | +8.8% | +27.1% | CHE higher |
| ROA FY2025, SEC XBRL | +6.7% | +17.2% | CHE higher |
| Debt / equity as of 2026-09-03 | 0.05 | 0.21 | ADUS lower |
| Revenue growth (YoY) as of 2026-09-03 | +15.9% | +3.3% | ADUS higher |
| Revenue CAGR (3y) SEC XBRL | +14.4% | +5.8% | ADUS higher |
| Dividend yield as of 2026-09-03 | n/a | +0.6% | |
| Dividend streak (yrs) SEC XBRL | 0 | 18 | CHE higher |
| Beta as of 2026-09-03 | 0.39 | 0.22 | |
| 1-year return as of 2026-10-09 close | -0.0% | +15.9% | CHE higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.